
-
2010
Company Description
Amakem is a kinase platform company developing therapeutics for the treatment of serious eye conditions.
Amakem is a kinase platform company focusing on ophthalmology and is developing new treatments for serious eye conditions. Amakem's product pipeline is based on its unique ‘Localized Drug Action' platform which is designed to generate safe and effective novel kinase inhibitors that minimize systemic exposure with the aim of reducing side effects.
-
Manufacturer:
Science and Engineering -
Formed:
2010 -
Founders:
Dirk Leysen -
Company Website:
-
Company E-mail:
-
Company Address:
Agoralaan bldg. A bisDiepenbeekBelgium -
CEO:
- Dirk Leysen
-
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits